Literature DB >> 22452619

Chronic urinary retention in men: how we define it, and how does it affect treatment outcome.

Carlo L A Negro1, Gordon H Muir.   

Abstract

What's known on the subject? and What does the study add? Chronic urinary retention (CUR) is a poorly defined entity, as the key element of definition, significant postvoid residual urine volume (PVR), has not a worldwide and moreover evidenced-based definition. There is no agreement on which is the threshold value to define a significant PVR and different society produced guidelines with different thresholds ranging from 300 mL to 1000 mL. Diagnosis is difficult, and management has not been defined yet. There is a lack of studies on the best management of these patients, as this group of patients has always been considered at high risk of failure. Only one study compares conservative with the surgical management but it is not a randomised controlled trail. This review offers a systematic appraisal of the most recent publications on CUR. It indicates the absence of a real worldwide agreed definition, as the two keys element of it are not satisfactorily defined yet: significant PVR, is suffering from a lack of evidenced-based definition, and percussable or palpable bladder is a very nebulous concept as it is not a criteria of certainty as different individual variables affect it. This has an important effect on management which is not structured. Most of the trials involving benign prostatic hyperplasia treatments (either medical or surgical) tend to exclude this group of patients, which is a clinically important group, comprising up to a quarter of men undergoing TURP in the UK. Urinary retention describes a bladder that does not empty completely or does not empty at all. Historically, urinary retention has been classified as either acute or chronic the latter is generally classified as high pressure or low pressure according to the bladder filling pressure on urodynamic. A MEDLINE® search for articles written in English and published before January 2010 was done using a list of terms related to urinary retention: 'urinary retention', 'chronic urinary retention' and 'PVR'. Chronic urinary retention (CUR) is defined by the International Continence Society as 'a non-painful bladder, which remains palpable or percussable after the patient has passed urine'. Abrams was the first to choose a residual urine volume >300 mL to define CUR as he considered it the minimum volume at which the bladder becomes palpable suprapubically. The UK National Institute for Health and Clinical Excellence lower urinary tract symptoms (LUTS) guidelines define CUR as a postvoid residual urine volume (PVR) of >1000 mL. No studies have specifically addressed the problem of quantifying the minimum amount of urine present in the bladder to define CUR. Nor did we find any publications objectively assessing at what amount of urine a bladder can be palpable. The ability to feel a bladder may rely on variables (i.e. medical skills and patient habitus). There is a marked variability of PVR, so the test should be repeated to improve precision. As defining CUR is difficult, structured management is challenging. Nearly all prospective trials exclude men with CUR from analysis, possibly anticipating a poor outcome and a high risk of complications. However, men with CUR are a clinically important group, comprising up to 25% of men undergoing transurethral resection of the prostate. Definition of CUR is imprecise and arbitrary. Most studies seem to describe the condition as either a PVR of >300 mL in men who are voiding, or >1000 mL in men who are unable to void. This confusion leads to an inability to design and interpret studies; indeed most prospective trials simply exclude these patients. There is a clear need for internationally accepted definitions of retention to allow both treatment and reporting of outcomes in men with LUTS, and for such definitions to be used by all investigators in future trials.
© 2012 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2012        PMID: 22452619     DOI: 10.1111/j.1464-410X.2012.11101.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  23 in total

1.  Picking your prostates.

Authors:  Blayne Welk
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

Review 2.  Can Long-term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention?

Authors:  Fabrizio Presicce; Cosimo De Nunzio; Andrea Tubaro
Journal:  Curr Urol Rep       Date:  2017-09       Impact factor: 3.092

Review 3.  Non-neurogenic Chronic Urinary Retention: What Are We Treating?

Authors:  John T Stoffel
Journal:  Curr Urol Rep       Date:  2017-09       Impact factor: 3.092

4.  Prolonged nonobstructive urinary retention induced by tibial nerve stimulation in cats.

Authors:  Shun Li; Jeffery Browning; Katherine Theisen; Todd Yecies; Bing Shen; Jicheng Wang; James R Roppolo; William C de Groat; Changfeng Tai
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-01-08       Impact factor: 3.619

5.  Transurethral prostate surgery as a preventive method against progression of chronic kidney disease in patients with urodynamically proven bladder outlet obstruction.

Authors:  Dong Sup Lee; Hyung Wook Kim; Seung-Ju Lee
Journal:  World J Urol       Date:  2019-12-04       Impact factor: 4.226

Review 6.  Clinical Implications for the Early Treatment of Benign Prostatic Enlargement (BPE): a Systematic Review.

Authors:  Fabrizio Presicce; Cosimo De Nunzio; Andrea Tubaro
Journal:  Curr Urol Rep       Date:  2018-07-09       Impact factor: 3.092

7.  HoLEP for acute and non-neurogenic chronic urinary retention: how effective is it?

Authors:  Tevita Aho; William Finch; Philippa Jefferson; Lokesh Suraparaju; Fanourios Georgiades
Journal:  World J Urol       Date:  2021-03-24       Impact factor: 4.226

8.  Superficial peroneal neuromodulation of nonobstructive urinary retention in cats.

Authors:  Jun Zhao; Jialiang Chen; Wenbin Guo; Katherine Shapiro; Anand Mohapatra; Yihua Zhong; Kody Armann; Bing Shen; Jicheng Wang; Jonathan Beckel; William C de Groat; Changfeng Tai
Journal:  Neurourol Urodyn       Date:  2020-06-16       Impact factor: 2.696

9.  Efficacy and tolerability of solifenacin in men with overactive bladder: results of an observational study.

Authors:  Maximilian Burger; Dietmar Betz; Christian Hampel; Monika Vogel
Journal:  World J Urol       Date:  2013-10-18       Impact factor: 4.226

10.  A prevalence survey of patients with indwelling urinary catheters on district nursing caseloads in the United Kingdom: The Community Urinary Catheter Management (CCaMa) Study.

Authors:  Jacqui Prieto; Jennie Wilson; Aggie Bak; Andrea Denton; Ashley Flores; Gail Lusardi; Matthew Reid; Lesley Shepherd; Niamh Whittome; Heather Loveday
Journal:  J Infect Prev       Date:  2020-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.